Detalhe da pesquisa
1.
Histone Deacetylation Inhibitors as Modulators of Regulatory T Cells.
Int J Mol Sci
; 21(7)2020 Mar 29.
Artigo
Inglês
| MEDLINE | ID: mdl-32235291
2.
Persistently Elevated Plasma Concentrations of RIPK3, MLKL, HMGB1, and RIPK1 in Patients with COVID-19 in the Intensive Care Unit.
Am J Respir Cell Mol Biol
; 67(3): 405-408, 2022 09.
Artigo
Inglês
| MEDLINE | ID: mdl-35385375
3.
Suberoylanilide hydroxamic acid synergistically enhances the antitumor activity of etoposide in Ewing sarcoma cell lines.
Anticancer Drugs
; 26(8): 843-51, 2015 Sep.
Artigo
Inglês
| MEDLINE | ID: mdl-26053276
4.
Angiotensin II treatment in COVID-19 patients: more risk than benefit? A single-center experience.
Crit Care
; 24(1): 409, 2020 07 09.
Artigo
Inglês
| MEDLINE | ID: mdl-32646469
5.
Strong apoptotic response of testis tumor cells following cisplatin treatment.
Int Urol Nephrol
; 56(3): 1007-1017, 2024 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-37891379
6.
EVIDENCE FROM FATAL COVID-19 FOR TARGETING THE BRADYKININ METABOLISM-A SINGLE-CENTER COHORT STUDY.
Shock
; 60(6): 727-738, 2023 12 01.
Artigo
Inglês
| MEDLINE | ID: mdl-37878473
7.
Endogenous anti-tumorigenic nitro-fatty acids inhibit the ubiquitin-proteasome system by directly targeting the 26S proteasome.
Cell Chem Biol
; 30(10): 1277-1294.e12, 2023 10 19.
Artigo
Inglês
| MEDLINE | ID: mdl-37473760
8.
Antioxidants as Therapeutic Agents in Acute Respiratory Distress Syndrome (ARDS) Treatment-From Mice to Men.
Biomedicines
; 10(1)2022 Jan 04.
Artigo
Inglês
| MEDLINE | ID: mdl-35052778
9.
HIGH HEPARANASE LEVEL IN SURVIVORS OF COVID-19 - INDICATOR OF VASCULAR AND PULMONARY RECOVERY?
Shock
; 58(6): 514-523, 2022 12 01.
Artigo
Inglês
| MEDLINE | ID: mdl-36548643
10.
Nrf2-A Molecular Target for Sepsis Patients in Critical Care.
Biomolecules
; 10(12)2020 12 17.
Artigo
Inglês
| MEDLINE | ID: mdl-33348637
11.
The Emerging Therapeutic Potential of Nitro Fatty Acids and Other Michael Acceptor-Containing Drugs for the Treatment of Inflammation and Cancer.
Front Pharmacol
; 11: 1297, 2020.
Artigo
Inglês
| MEDLINE | ID: mdl-33013366
12.
BCL-2 selective inhibitor ABT-199 primes rhabdomyosarcoma cells to histone deacetylase inhibitor-induced apoptosis.
Oncogene
; 37(39): 5325-5339, 2018 09.
Artigo
Inglês
| MEDLINE | ID: mdl-29858601
13.
BCL-xL-selective BH3 mimetic sensitizes rhabdomyosarcoma cells to chemotherapeutics by activation of the mitochondrial pathway of apoptosis.
Cancer Lett
; 412: 131-142, 2018 01 01.
Artigo
Inglês
| MEDLINE | ID: mdl-28947136
14.
Neuroblastoma cells depend on HDAC11 for mitotic cell cycle progression and survival.
Cell Death Dis
; 8(3): e2635, 2017 03 02.
Artigo
Inglês
| MEDLINE | ID: mdl-28252645
15.
JNJ-26481585 primes rhabdomyosarcoma cells for chemotherapeutics by engaging the mitochondrial pathway of apoptosis.
Oncotarget
; 6(35): 37836-51, 2015 Nov 10.
Artigo
Inglês
| MEDLINE | ID: mdl-26473375
16.
Chemosensitization of rhabdomyosarcoma cells by the histone deacetylase inhibitor SAHA.
Cancer Lett
; 351(1): 50-8, 2014 Aug 28.
Artigo
Inglês
| MEDLINE | ID: mdl-24814395